WuXi Advanced Therapies Employee Directory

Biotechnology ResearchPennsylvania, United States501-1000 Employees

Advanced Therapies is a cell therapy Contract Testing, Development and Manufacturing Organization (CTDMO.) We leverage our significant experience and proven track record in development and manufacturing, as well as expert testing services, to enable advanced therapies to be developed, manufactured and released faster and with greater predictability, thereby reducing the complexities and cost of high-touch, multi-vendor production models. 
On 7 March 2025, Advanced Therapies U.S. and our discovery arm, OXGENE (www.oxgene.com) were purchased by Altaris, an investment firm headquartered in the U.S. with an exclusive focus on the healthcare industry. With a 20+ year track record that includes 11 medical product CDMOs, Altaris is well-positioned to support Advanced Therapies over its next phase of growth. 
This transaction builds on Altaris’ strategic initiative for the cell and gene therapy market, which is focused on delivering life-changing therapies to patients at scale. As part of this strategy, Altaris acquired Minaris Regenerative Medicine (“Minaris”) from Resonac Holdings Corporation in January of this year. Minaris is a cell therapy contract development and manufacturing organization (CDMO) with operations in the United States, Germany and Japan.
Altaris intends to combine Advanced Therapies and Minaris into a single company, Minaris Advanced Therapies. The combined company’s extensive track record, breadth of capabilities and global manufacturing footprint will enhance our ability to service our customers, accelerate development timelines, reduce manufacturing costs, and improve patient access to life-saving treatments.
For now, Minaris and Advanced Therapies will continue to operate as two independent companies to ensure business continuity until the completion of certain separation milestones from their respective former parent companies. We expect them to be fully combined by the end of 2025.

Find WuXi Advanced Therapies employees' phone numbers or email addresses

WuXi Advanced Therapies Global Highlights

Location
Employees

North America
250

Minus sign iconPlus sign icon
  • United States Of America
    250

Asia
10

Minus sign iconPlus sign icon
  • China
    10

Europe
1

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1

WuXi Advanced Therapies's Leadership

  • Stylized image of a person
    R. F.
    Chief Operations Officer
    Phone icon
  • Stylized image of a person
    C. Y.
    Head Of Commercial,china
    Phone icon
  • Stylized image of a person
    J. D.
    Owner
    Phone icon
  • Stylized image of a person
    I. I.
    Director Of Clinical Manufacturing Ops - Cell & Gene Therapy
    Phone icon
  • Stylized image of a person
    C. F.
    Director Of It Infrastructure
    Phone icon
  • Stylized image of a person
    D. C.
    Director Of Cell Therapy Manufacturing
    Phone icon
  • Stylized image of a person
    A. C. S.
    Director
    Phone icon
  • Stylized image of a person
    A. H.
    Associate Director Of Procurement
    Phone icon

WuXi Advanced Therapies Employee Metrics

100%
50%
0%
2026
2025
2024
  • Research
  • Manufacturing
  • Quality Assurance
  • Operations
  • Program & Project Management
  • Other
  • Environmental Services

Contact profiles from WuXi Advanced Therapies

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    J. D.
    Technical Project Manager I
    Phone icon
    United StatesDelaware
    Oct 22, 2024
  • Stylized image of a person
    J. R.
    Senior Marketing Manager
    Phone icon
    United StatesPennsylvania
    Oct 23, 2024
  • Stylized image of a person
    K. R.
    Senior Manager
    Phone icon
    United StatesPennsylvania
    Oct 16, 2024
  • Stylized image of a person
    K. W.
    Manager
    Phone icon
    United StatesNew York
    Apr 23, 2025
  • Stylized image of a person
    L. L.
    Team Lead
    Phone icon
    UNITED STATES
    Oct 22, 2024
  • Stylized image of a person
    M. G.
    Regional Account Manager
    Phone icon
    UNITED STATES
    Mar 08, 2023
  • Stylized image of a person
    M. A.
    Senior Project Manager
    Phone icon
    Oct 16, 2024
  • Stylized image of a person
    M. P.
    Manager Regulatory Affairs
    Phone icon
    Oct 28, 2025
  • Stylized image of a person
    P. M.
    Senior Finance Manager Advanced Therapies
    Phone icon
    Oct 22, 2024
  • Stylized image of a person
    S. Z.
    Lead Laboratory Technician
    Phone icon
    United StatesGeorgia
    Jul 30, 2025

Frequently Asked Questions

What is WuXi Advanced Therapies known for?

Minus sign iconPlus sign icon
WuXi Advanced Therapies was founded in 2004 operates in the Biotechnology Research industry. Explore WuXi Advanced Therapies's company overview page for more information.

What is WuXi Advanced Therapies's most common email format?

Minus sign iconPlus sign icon
WuXi Advanced Therapies employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more WuXi Advanced Therapies email formats with LeadIQ.

How many employees does WuXi Advanced Therapies have currently?

Minus sign iconPlus sign icon
WuXi Advanced Therapies has approximately 501 employees as of December 2025. These team members are located across 3 continents, including North AmericaAsiaEurope.

Who are WuXi Advanced Therapies's key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, WuXi Advanced Therapies's key employees include:

  • Chief Operations Officer: R. F.
  • Head Of Commercial,china: C. Y.
  • Owner: J. D.
  • Director Of Clinical Manufacturing Ops - Cell & Gene Therapy: I. I.
  • Director Of It Infrastructure: C. F.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.